10|18|24

The Real Threat to Creatives Isn’t GenAI; It’s a Content Supply Chain That Can’t Keep Pace With Their Innovation

As we stand at the intersection of creativity and technology, a common question arises: Will generative AI (GenAI) make creatives obsolete? Susan Perlbachs, Chief Creative Officer, details why the answer that echoed through Adobe MAX 2024 was a firm no. Read the blog to learn more.

10|15|24

Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies

Discover how EVERSANA’s cutting-edge approach is revolutionizing patient identification for cell and gene therapies. In our white paper, “Lead Time Is All You Need: Patient Identification for Cell and Gene Therapies Using Machine Learning and Advanced Data Analytics,” we explore the transformative power of machine learning and advanced data analytics in the world of healthcare.

10|07|24

How AI Makes the Voice of the Consumer Louder

How does your organization make marketing decisions? Artificial intelligence (AI) is revolutionizing the way pharmaceutical companies make marketing decisions, and EVERSANA INTOUCH is at the forefront of this transformation. In this POV, John Kenny, EVP and Head of Strategic Planning, delves into the innovative use of AI-powered personas to keep the customer’s perspective central in […]

10|04|24

EVERSANA INTOUCH Shines at the 2024 PM360 Trailblazer Awards with Five Wins 

The 16th annual PM360 Trailblazer Awards was a night to remember for EVERSANA INTOUCH! Our team was honored at Gotham Hall in New York City, taking home five awards across several categories: 

09|30|24

Angela Tenuta on How Brands Can Transform their Content Velocity

Taking a deeper dive into our recent POV, Content Velocity: Mastering the Three Pillars of Success, Angela Tenuta, President, Agency, covers how pharmaceutical companies can master content velocity to deliver brand content with unparalleled speed, precision and reach in pharmaphorum’s most recent Deep Dive Magazine. 

09|27|24

Behind the Breakthroughs and Practice-Changing Advances: Insights from ESMO 2024

Gurdip Daffu, VP, Medical Strategy; Anne Marie Robertson, EVP, EVERSANA ONCOLOGY Commercialization™; Vanitha Sankaran, VP, Medical Strategy; Barry Vucsko, SVP, Strategic Development Every year, the European Society for Medical Oncology (ESMO) brings together experts from pharma, research and advocacy organizations, and healthcare providers (HCPs) to hear about the year’s biggest oncology breakthroughs. With the theme […]

09|26|24

How Real Is AI – Really – in Pharmaceutical Marketing?

Artificial intelligence (AI) is transforming almost every industry. In healthcare, we hear how AI is being used to discover new drugs, help surgeons perform surgeries remotely and even diagnose conditions. Download the POV to see 10 ways we're "pharmatizing" AI.

09|20|24

Unleashing the Power of AI: Predictive Analytics in Healthcare Marketing

Predictive analytics is revolutionizing healthcare marketing by leveraging AI to make data-driven decisions. In this POV, we explore how the use of predictive models enhances engagement by targeting the right audiences, optimizing marketing strategies and best utilizing marketing dollars.

09|12|24

Emotional Storytelling and AI in Health Marketing

Nicholas Capanear, Executive Creative Director, was recently featured in the Sports + Health edition of Lürzer’s Archive. In the article, Nicholas highlights the evolving versatility of health marketing and driving fresh and innovative creative approaches. Read the article to learn more.

09|10|24

With Ads on Threads, Is It Time for an All-Meta Strategy?

Justin Chase, EVP, Media, was recently published in Med Ad News discussing the benefits of using Meta's buying platform including exactly how much cost savings advertisers can find and how. Read the article to learn more.